TRPV1 channels mediate long-term depression at synapses on hippocampal interneurons

被引:314
作者
Gibson, Helen E. [1 ]
Edwards, Jeffrey G. [1 ]
Page, Rachel S. [1 ]
Van Hook, Matthew J. [1 ]
Kauer, Julie A. [1 ]
机构
[1] Brown Univ, Dept Mol Pharmacol Physiol & Biotechnol, Providence, RI 02912 USA
关键词
D O I
10.1016/j.neuron.2007.12.027
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
TRPV1 receptors have classically been defined as heat-sensitive, ligand-gated, nonselective cation channels that integrate nociceptive stimuli in sensory neurons. TRPV1 receptors have also been identified in the brain, but their physiological role is poorly understood. Here we report that TRPV1 channel activation is necessary and sufficient to trigger long-term synaptic depression (LTD). Excitatory synapses onto hippocampal interneurons were depressed by either capsaicin, a potent TRPV1 channel activator, or the endogenously released eicosanoid, 12-(S)HPETE, whereas neighboring excitatory synapses onto CA1 pyramidal cells were unaffected. TRPV1 receptor antagonists also prevented interneuron LTD. In brain slices from TRPV1(-/-) mice, LTD was absent, and neither capsaicin nor 12-(S)-HPETE elicited synaptic depression. Our results suggest that, in the hippocampus, TRPV1 receptor activation selectively modifies synapses onto interneurons. Like other forms of hippocampal synaptic plasticity, TRPV1-mediated LTD may have a role in long-term changes in physiological and pathological circuit behavior during learning and epileptic activity.
引用
收藏
页码:746 / 759
页数:14
相关论文
共 75 条
[61]   Hot receptors in the brain [J].
Steenland, Hendrik W. ;
Ko, Shanelle W. ;
Wu, Long-Jun ;
Zhuo, Min .
MOLECULAR PAIN, 2006, 2
[62]   Pharmacological characterization of vanilloid receptor located in the brain [J].
Szabo, T ;
Biro, T ;
Gonzalez, AF ;
Palkovits, M ;
Blumberg, PM .
MOLECULAR BRAIN RESEARCH, 2002, 98 (1-2) :51-57
[63]   Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse? [J].
Szallasi, A ;
Appendino, G .
JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (11) :2717-2723
[64]  
Szallasi A, 1999, PHARMACOL REV, V51, P159
[65]   TRPV1: a therapeutic target for novel analgesic drugs? [J].
Szallasi, Arpad ;
Cruz, Francisco ;
Geppetti, Pierangelo .
TRENDS IN MOLECULAR MEDICINE, 2006, 12 (11) :545-554
[66]   The CB1 cannabinoid receptor mediates glutamatergic synaptic suppression in the hippocampus [J].
Takahashi, K. A. ;
Castillo, P. E. .
NEUROSCIENCE, 2006, 139 (03) :795-802
[67]   The cloned capsaicin receptor integrates multiple pain-producing stimuli [J].
Tominaga, M ;
Caterina, MJ ;
Malmberg, AB ;
Rosen, TA ;
Gilbert, H ;
Skinner, K ;
Raumann, BE ;
Basbaum, AI ;
Julius, D .
NEURON, 1998, 21 (03) :531-543
[68]   Expression and distribution of vanilloid receptor 1 (TRPV1) in the adult rat brain [J].
Tóth, A ;
Boczán, J ;
Kedei, N ;
Lizanecz, E ;
Bagi, Z ;
Papp, Z ;
Édes, I ;
Csiba, L ;
Blumberg, PM .
MOLECULAR BRAIN RESEARCH, 2005, 135 (1-2) :162-168
[69]   Therapeutic potential of targeting the endocannabinoids: Implications for the treatment of obesity, metabolic syndrome, drug abuse and smoking cessation [J].
Tucci, S. A. ;
Halford, J. C. G. ;
Harrold, J. A. ;
Kirkham, T. C. .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (22) :2669-2680
[70]   Endovanilloids - Putative endogenous ligands of transient receptor potential vanilloid 1 channels [J].
van der Stelt, M ;
Di Marzo, V .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2004, 271 (10) :1827-1834